Summary
This prediction ended on 10.01.11 with a price of €15.43. With a performance of -7.39%, the BUY prediction for QIAGEN NV by melinda closed slightly in the red. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| QIAGEN NV | - | - | - | - |
| iShares Core DAX® | -3.520% | -4.987% | 1.926% | 50.820% |
| iShares Nasdaq 100 | 0.261% | 1.102% | 15.434% | 90.843% |
| iShares Nikkei 225® | -4.953% | -3.352% | 29.010% | 51.211% |
| iShares S&P 500 | -0.823% | -0.042% | 10.814% | 62.945% |
According to melinda what are the pros and cons of QIAGEN NV for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread QIAGEN NV diskutieren
Biotechnologie
QIAGEN Marktführer in manuellen und automatisierten Aufreinigung von Nukleinsäuren ACDE Life-Science-Produkten für den Nachweis menschlicher Krankheitserreger
(Laufzeit überschritten)